Shares of Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report) traded down 4.2% during trading on Monday. The stock traded as low as $3.5401 and last traded at $3.83. 20,072 shares traded hands during mid-day trading, a decline of 47% from the average session volume of 37,647 shares. The stock had previously closed at $4.00.
Invizyne Technologies Stock Performance
The company’s 50 day simple moving average is $5.01 and its two-hundred day simple moving average is $7.38.
Invizyne Technologies Company Profile
Invizyne Technologies is a biotechnology company developing cell-free biomanufacturing technology. Its platform uses enzymes outside living cells to carry out biological production processes, offering an alternative to manufacturing methods that depend on growing engineered microorganisms. The company’s technology is designed to produce complex molecules for potential use in areas such as pharmaceuticals, chemicals, and other products made through biological processes. Invizyne focuses on developing and scaling its platform and evaluating applications with commercial potential.
Recommended Stories
- Five stocks we like better than Invizyne Technologies
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
